๐ฐ Diabetes Sci News
Diabetes Sci News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diabetes Sci. Real-time updates on events, politics, business and more.
June 3, 2024
03.06.2024 - Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet ...
February 6, 2024
Dexcom ONE+ is available today in Spain, Belgium, and Poland with the Netherlands launching next week, and additional countries to be announced in the coming months. New system continues to...
December 6, 2023
Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.
October 5, 2023
BURNABY, British Columbia--(BUSINESS WIRE)--Oct 5, 2023--
September 1, 2023
Analysis of claims data showed reduced utilization and costs among patients with nonintensively treated type 2 diabetes (T2D) using self-monitoring of blood glucose compared with continuous glucose monitoring.
August 18, 2023
CMS began reimbursement for nonโface-to-face chronic care management in 2015, and results from Louisiana show that it increases outpatient visits but decreases inpatient and emergency department encounters.
April 17, 2023
Medicare patients using all types of insulin now have coverage for Dexcom G7* – giving approximately 1.5 million more Americans access to the most accurate,1 simple to use1 CGM at the same... | April 17, 2023
April 10, 2023
Continuous glucose monitoring has been firmly established as beneficial for helping people with diabetes understand their glucose profile, but whether these metrics translate for people without diabetes is still unclear. In a study published in Diabetes Technology & Therapeutics, researchers found a discordance between glucose management indicator (GMI), a CGM metric that estimates
February 8, 2023
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today unveiled the companyโs second Super Bowl commercial, which announces the US launch of its next-generation Dexcom G7 CGM System.
December 15, 2022
Consuming too many sugar-laden treats during the holiday season has been linked to various metabolic, inflammatory and biological ...